생리학용 전임상 소프트웨어 시장(2026-2030년)

The global preclinical software for physiology da and as market is forecasted to grow by USD 4167.7 mn during 2025-2030, accelerating at a CAGR of 5.4% during the forecast period. The report on the global preclinical software for physiology da and as market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by emerging role of bioinformatics tools and software in preclinical research, increasing awareness of physiological monitoring in preclinical research, increasing use of animals in preclinical studies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global preclinical software for physiology da and as market is segmented as below:

By End-User

• Industrial labs and CROs
• Academic government and research labs

By Deployment

• On-premises
• Cloud

By Application

• Physiology research
• Drug development and safety testing
• Behavioral studies
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • The Netherlands
  • Spain
  • Russia
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the rising digitalization in preclinical research as one of the prime reasons driving the global preclinical software for physiology da and as market growth during the next few years. Also, increasing outsourcing of preclinical research and growing demand for send submission software for preclinical data will lead to sizable demand in the market.

The report on the global preclinical software for physiology da and as market covers the following areas:

• Global preclinical software for physiology da and as market sizing
• Global preclinical software for physiology da and as market forecast
• Global preclinical software for physiology da and as market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global preclinical software for physiology da and as market vendors that include ADInstruments Pty Ltd., BIOPAC Systems Inc., Bruker Corp., Columbus Instruments LLC, emka TECHNOLOGIES, ETISENSE SAS, Harvard Bioscience Inc., Instem Plc, Med Associates Inc., Noldus Information Technology, PerkinElmer US LLC, Starr Life Sciences Corp., Stoelting Co., Thermo Fisher Scientific Inc., TSE Systems GmbH, UGO BASILE S.R.L., Xybion Digital Inc., Zaber Technologies Inc.. Also, the global preclinical software for physiology da and as market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Deployment
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Preclinical Software For Physiology DA And AS Market 2020 - 2024
  • Historic Market Size - Data Table on Global Preclinical Software For Physiology DA And AS Market 2020 - 2024 ($ million)
• 5.2 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.3 Deployment segment analysis 2020 - 2024
  • Historic Market Size - Deployment Segment 2020 - 2024 ($ million)
• 5.4 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Preclinical Software for Physiology DA and AS Market
• 6.2 Impact of Geopolitical Conflicts on Global Preclinical Software for Physiology DA and AS Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by End-user

• 8.1 Market segments
• 8.2 Comparison by End-user
• 8.3 Industrial labs and CROs - Market size and forecast 2025-2030
• 8.4 Academic government and research labs - Market size and forecast 2025-2030
• 8.5 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

9 Market Segmentation by Deployment

• 9.1 Market segments
• 9.2 Comparison by Deployment
• 9.3 On-premises - Market size and forecast 2025-2030
• 9.4 Cloud - Market size and forecast 2025-2030
• 9.5 Market opportunity by Deployment
  • Market opportunity by Deployment ($ million)

10 Market Segmentation by Application

• 10.1 Market segments
• 10.2 Comparison by Application
• 10.3 Physiology research - Market size and forecast 2025-2030
• 10.4 Drug development and safety testing - Market size and forecast 2025-2030
• 10.5 Behavioral studies - Market size and forecast 2025-2030
• 10.6 Others - Market size and forecast 2025-2030
• 10.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 The Netherlands - Market size and forecast 2025-2030
  • 12.4.6 Spain - Market size and forecast 2025-2030
  • 12.4.7 Russia - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 South Korea - Market size and forecast 2025-2030
  • 12.5.4 India - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
  • 12.5.7 Singapore - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Australia - Market size and forecast 2025-2030
  • 12.6.2 Brazil - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.5 South Africa - Market size and forecast 2025-2030
  • 12.6.6 Turkey - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Emerging role of bioinformatics tools and software in preclinical research
  • Increasing awareness of physiological monitoring in preclinical research
  • Increasing use of animals in preclinical studies
• 13.2 Market challenges
  • Stringent ethical framework using animals in preclinical research
  • Characteristic disadvantages of animal studies
  • Lack of technical expertise in preclinical research
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Rising digitalization in preclinical research
  • Increasing outsourcing of preclinical research
  • Growing demand for SEND submission software for preclinical data

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 ADInstruments Pty Ltd.
  • ADInstruments Pty Ltd. - Overview
  • ADInstruments Pty Ltd. - Product / Service
  • ADInstruments Pty Ltd. - Key offerings
  • SWOT
• 15.5 BIOPAC Systems Inc.
  • BIOPAC Systems Inc. - Overview
  • BIOPAC Systems Inc. - Product / Service
  • BIOPAC Systems Inc. - Key offerings
  • SWOT
• 15.6 Bruker Corp.
  • Bruker Corp. - Overview
  • Bruker Corp. - Business segments
  • Bruker Corp. - Key news
  • Bruker Corp. - Key offerings
  • Bruker Corp. - Segment focus
  • SWOT
• 15.7 Columbus Instruments LLC
  • Columbus Instruments LLC - Overview
  • Columbus Instruments LLC - Product / Service
  • Columbus Instruments LLC - Key offerings
  • SWOT
• 15.8 ETISENSE SAS
  • ETISENSE SAS - Overview
  • ETISENSE SAS - Product / Service
  • ETISENSE SAS - Key offerings
  • SWOT
• 15.9 Harvard Bioscience Inc.
  • Harvard Bioscience Inc. - Overview
  • Harvard Bioscience Inc. - Product / Service
  • Harvard Bioscience Inc. - Key offerings
  • SWOT
• 15.10 Med Associates Inc.
  • Med Associates Inc. - Overview
  • Med Associates Inc. - Product / Service
  • Med Associates Inc. - Key offerings
  • SWOT
• 15.11 Noldus Information Technology
  • Noldus Information Technology - Overview
  • Noldus Information Technology - Product / Service
  • Noldus Information Technology - Key offerings
  • SWOT
• 15.12 PerkinElmer US LLC
  • PerkinElmer US LLC - Overview
  • PerkinElmer US LLC - Product / Service
  • PerkinElmer US LLC - Key offerings
  • SWOT
• 15.13 Starr Life Sciences Corp.
  • Starr Life Sciences Corp. - Overview
  • Starr Life Sciences Corp. - Product / Service
  • Starr Life Sciences Corp. - Key offerings
  • SWOT
• 15.14 Stoelting Co.
  • Stoelting Co. - Overview
  • Stoelting Co. - Product / Service
  • Stoelting Co. - Key offerings
  • SWOT
• 15.15 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT
• 15.16 TSE Systems GmbH
  • TSE Systems GmbH - Overview
  • TSE Systems GmbH - Product / Service
  • TSE Systems GmbH - Key offerings
  • SWOT
• 15.17 Xybion Digital Inc.
  • Xybion Digital Inc. - Overview
  • Xybion Digital Inc. - Product / Service
  • Xybion Digital Inc. - Key offerings
  • SWOT
• 15.18 Zaber Technologies Inc.
  • Zaber Technologies Inc. - Overview
  • Zaber Technologies Inc. - Product / Service
  • Zaber Technologies Inc. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations